Kevin D. Read
Impact in
-
- Research on Leishmaniasis Studies
- Epidemiology top 2%
- Trypanosoma species research and implications
Papers in
- Epidemiology 33
- Trypanosoma species research and implications 33
-
- Research on Leishmaniasis Studies 25
- Co-authors
- Alan H. Fairlamb (15 shared papers)Ian H. Gilbert (26 shared papers)Susan Wyllie (11 shared papers)Paul G. Wyatt (19 shared papers)Suzanne Norval (15 shared papers)Manu De Rycker (10 shared papers)David Horn (7 shared papers)Laste Stojanovski (14 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)ChemMedChem (6 papers)Nature Reviews Microbiology (5 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)PLoS Pathogens (3 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Kevin D. Read
75 papers receiving 3.0k citations
Kevin D. Read's Hit Papers
Peers
Comparison fields: 5 of 118
- Public Health, Environmental and Occupational Health 960
- Epidemiology 1.1k
- Organic Chemistry 780
- Toxicology 86
- Parasitology 154
Countries citing papers authored by Kevin D. Read
This map shows the geographic impact of Kevin D. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin D. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin D. Read more than expected).
Fields of papers citing papers by Kevin D. Read
This network shows the impact of papers produced by Kevin D. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin D. Read. The network helps show where Kevin D. Read may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin D. Read, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need Hit paper breakdown → | 2017 | 309 |
| 2 | 2007 | 230 | |
| 3 | 2016 | 181 | |
| 4 | 2012 | 125 | |
| 5 | 2017 | 123 | |
| 6 | 2022 | 108 | |
| 7 | 2010 | 102 | |
| 8 | 2011 | 94 | |
| 9 | 2009 | 80 | |
| 10 | 2011 | 78 | |
| 11 | 2016 | 69 | |
| 12 | 2016 | 68 | |
| 13 | 2016 | 61 | |
| 14 | 2010 | 57 | |
| 15 | 2013 | 53 | |
| 16 | 2020 | 52 | |
| 17 | 2008 | 51 | |
| 18 | 2010 | 51 | |
| 19 | 2018 | 49 | |
| 20 | 2010 | 48 |
About Kevin D. Read
Kevin D. Read is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health, Molecular Biology, Organic Chemistry and Computational Theory and Mathematics, having authored 77 papers that have together received 3.1k indexed citations. Recurring topics across this work include Trypanosoma species research and implications (33 papers), Research on Leishmaniasis Studies (25 papers), Synthesis and Biological Evaluation (16 papers), Computational Drug Discovery Methods (9 papers), Ubiquitin and proteasome pathways (6 papers), Biochemical and Molecular Research (6 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (960 citations), Epidemiology (1.1k citations), Organic Chemistry (780 citations), Toxicology (86 citations) and Parasitology (154 citations). Kevin D. Read has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Alan H. Fairlamb, Ian H. Gilbert, Susan Wyllie, Paul G. Wyatt, Suzanne Norval, Manu De Rycker, David Horn, Laste Stojanovski, Stephen Patterson and Leah S. Torrie. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, Nature Reviews Microbiology, Journal of Pharmacology and Experimental Therapeutics and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.